Valuation: Asymchem Laboratories (Tianjin) Co., Ltd.

Market Cap 6.66TCr 993.99Cr 886.73Cr 826.12Cr 751.8Cr 1.42TCr 96TCr 1.43TCr 9.98TCr 3.88TCr 49TCr 3.73TCr 3.65TCr 1,57000Cr P/E 2026 *
50.2x
P/E 2027 * 37.9x
Enterprise Value 6.2TCr 924.28Cr 824.55Cr 768.19Cr 699.08Cr 1.32TCr 89TCr 1.33TCr 9.28TCr 3.61TCr 45TCr 3.47TCr 3.39TCr 1,46000Cr EV / Sales 2026 *
7.66x
EV / Sales 2027 * 6.43x
Free-Float
62.13%
Yield 2026 *
0.72%
Yield 2027 * 0.96%
Manager TitleAgeSince
Chief Executive Officer 70 07/10/1998
Chief Executive Officer 49 19/01/2022
President - -
Director TitleAgeSince
Director/Board Member 49 18/07/2011
Chairman 70 07/10/1998
Director/Board Member 65 18/07/2011
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 992.74Cr
+1.30%-3.28%+35.58%+102.70% 1,01900Cr
-0.08%-5.97%+33.71%+59.60% 61TCr
-0.37%-0.55%+13.75%+76.63% 47TCr
+1.32%-6.07%+57.91%+34.98% 34TCr
+0.19%-0.43%+20.60%+40.19% 34TCr
+0.43%-3.75%+10.00%+31.68% 27TCr
+1.18%-4.81%-7.04%+8.12% 24TCr
-0.28%-6.30%+34.96%+48.41% 22TCr
-0.33%-5.60%+25.74%+91.08% 18TCr
Average +0.31%-3.63%+25.02%+54.82% 40.92TCr
Weighted average by Cap. +0.48%-3.51%+28.05%+65.10%

Financials

2026 *2027 *
Net sales 808.85Cr 120.64Cr 107.62Cr 100.27Cr 91Cr 171.84Cr 12TCr 173.11Cr 1.21TCr 471.37Cr 5.93TCr 452.89Cr 443.12Cr 19TCr 980.29Cr 146.21Cr 130.44Cr 121.52Cr 110.59Cr 208.26Cr 14TCr 209.8Cr 1.47TCr 571.28Cr 7.19TCr 548.88Cr 537.04Cr 23TCr
Net income 141.17Cr 21Cr 19Cr 17Cr 16Cr 30Cr 2.03TCr 30Cr 211.46Cr 82Cr 1.03TCr 79Cr 77Cr 3.33TCr 181.75Cr 27Cr 24Cr 23Cr 21Cr 39Cr 2.61TCr 39Cr 272.24Cr 105.92Cr 1.33TCr 101.76Cr 100Cr 4.28TCr
Net Debt -467.34Cr -70Cr -62Cr -58Cr -53Cr -99Cr -6.71TCr -100.02Cr -700.01Cr -272.35Cr -3.43TCr -261.67Cr -256.02Cr -11TCr -365.59Cr -55Cr -49Cr -45Cr -41Cr -78Cr -5.25TCr -78Cr -547.6Cr -213.05Cr -2.68TCr -204.7Cr -200.28Cr -8.62TCr
Logo Asymchem Laboratories (Tianjin) Co., Ltd.
Asymchem Laboratories Tianjin Co Ltd is a China-based company mainly engaged in providing one-stop comprehensive services for pharmaceutical outsourcing. The Company's business includes customized research and development and production of small molecule drugs (CDMO), chemical macromolecule CDMO, clinical research services, formulation CDMO, biological macromolecule CDMO, technology output and synthetic biology. The Company's product categories cover peptides, oligonucleotides, monoclonal antibodies, antibody-conjugated drugs and messenger RNA. The Company mainly conducts its business in domestic and foreign markets.
Employees
10,617
Trader
Investor
Global
Quality
ESG MSCI
-
Ratings Surperformance© - Asymchem Laboratories (Tianjin) Co., Ltd.